Tag Archive for: #BJUI

Posts

Superstition

In 1948 BF Skinner put a pigeon in a box.  Unlike most of Skinner’s birds, this one did not have to learn a behavior, such as pecking a lever, to receive an edible reward. Food was automatically dispensed at fixed time intervals without fail, the pigeon simply had to wait. The fascinating development from this experiment was that after some few hours in the box the bird was performing an elaborate routine of behaviors; turns, head movements, foot raises, all presumably in an effort to bring about the reward. When a number of birds were placed in the same situation, each developed a unique routine to bring about reinforcement, that was forthcoming regardless. Whatever behavior they happened to be performing at the time of feeding was, by chance association, reinforced.

Skinner dubbed this phenomenon “superstitious behavior”. He extrapolated this to human activities that have no bearing on an outcome, but are nonetheless performed in an effort to bring about a favorable endpoint.  Repeatedly pushing the elevator call button to speed its arrival. Using loved ones birthdates when selecting lottery numbers. Wearing lucky socks to a job interview. In these cases decision making is faulty due to misperceived information, that an extraneous behavior will make a significant difference to outcomes.

Much superstitious behavior is harmless, albeit futile.  In surgery, we have the “Goodnight Stitch”. This is the added step in the procedure that maybe unnecessary, but makes us feel we have done something extra for patient safety, and will therefore sleep easier. If the patient does well, the behavior is reinforced. Equally we all know the power of a significant, memorable complication in influencing our behavior.

Real harm arises when, like a pigeon in a box, a surgeon becomes isolated. Sitting alone in the dark, relying on short-term patient outcome feedback, the surgeon may develop a dominant philosophy of “In my hands…”, or “Our experience is…”, that precludes service improvement based on robust evidence. It has been established since at least the mid 1990s that powdered surgical gloves increase the rate of symptomatic abdominal adhesions (Luijendijk R), but do any of us know a surgeon that persists in using them because “This has not been my experience”? At first glance, the geographically isolated surgeon would seem to be particularly vulnerable to this phenomenon, with few colleagues to provide a check on eccentric practice. Perhaps, however, the surgeon that separates themselves from the surgical community, regardless of geography, is of greater concern.

We have conferences, morbidity and mortality meetings, and audit to objectively assess our outcomes, and prevent us from becoming superstitious victims of anecdote. We can vicariously increase our experience through research based on thousands more patients than we will ever treat. If a surgeon avoids or minimizes these activities, they are vulnerable to systematic superstitious decision making.

As surgeons, we fiercely defend our right to autonomous practice, and rightly so. We must not become slaves to policies imposed by misinformed outsiders with agendas other than patient welfare. We must also seek to overcome undue internal influences on our decision making based on fear, lack of knowledge, and superstition.

James Duthie is a Uro-Oncology Trainee (Robot Surgery) at Peter MacCallum Cancer Centre, Melbourne. He is interested in Human Factors Engineering, & making people better through electronic means. @Jamesduthie1

 

Comments on this blog are now closed.

 

 

What prophylactic steps should we take to prevent DVT/PE after RARP?

Deep vein thromboses (DVT) and pulmonary embolism (PE) are rare, but potentially devastating, complications of major pelvic surgery. We have performed more than 1000 robot assisted radical prostatectomy (RARP) procedures in Central London (Lessons learned from 1000 RARP operations BJUI 2013;111(1):9-10.) and to date encountered just a couple of DVTs, as well as a single, non-fatal instance of PE. However, in the case of one of us (RK), a close relative passed away as a result of a PE 10 days after a routine hip replacement performed in Oxford, a very sad event which highlighted the very negative impact on the family of this preventable surgical complication.

Guidance from NICE recommends that evidence-based steps be taken to reduce the risk of venous thromboembolism (VTE). Failure to do so therefore renders us open to criticism if a DVT, or worse a PE, does develop. On the other hand, pelvic haematoma and haematuria are troublesome complications of RARP, the risks of which may be exacerbated by anticoagulation.

What therefore should we be doing to reduce the risk of before and after laparoscopic pelvic surgery? Few would disagree that TED stockings should be worn before and after surgery, but how long should they be retained, as many patients do find them rather uncomfortable? Calf compression boots during surgery and for 12 hours or so post-operatively should also be standard practice.

More contentious is the duration of use of low molecular weight heparin (LMWH). Some surgeons use a single dose immediately prior to the operation; we have used 5000 Units of Clexane post-operatively for 2-3 days. Orthopaedic surgeons are increasingly continuing LMWH for 28 days at home after joint replacement surgery, which carries a significant risk of VTE. Should we follow their lead? A simpler alternative from the patients’ viewpoint is daily use of one of the new oral anti-coagulants such as dabigatran.

Perhaps the most sensible approach clinically is to perform a risk assessment of all RALP candidates pre-operatively. A calf compression device and TED stockings should be used for all patients, together with LMWH, while in hospital. Those considered especially at risk with, for example, a BMI >30 (Becattini CA) (See Box 1), should usually go home for a month with either LMWH injections or daily oral dabigatran, or equivalent oral anticoagulant agent.

We would be most interested in the views, experiences and current practice of the readers of this piece. Please do post your own response.

 

Roger Kirby, Ben Challacombe and Prokar Dasgupta
The Prostate Centre, London W1G 8GT and Guy’s Hospital, King’s College London, King’s Health Partners

 

Comments on this blog are now closed.

The self-proclaimed King of the Urology twitter world

Howard Stern proclaimed himself the King of all Media; I have proclaimed myself the King of the Urology twitter world.  There is no basis for my claim.  I certainly do not have the most followers nor do I have regal heritage. If you repeat things often enough they simply become true on the web – so I’m happy to be the king

What is true is that I was the first academic urologist to take to the twitterverse in a persistent, snarky, timely, and – at times- academic manner. I coached the uro-twitterati including Declan (@declangmurphy), Quoc (@qdtrinh),  Alex (@uretericbud), Coops (@cooperberg_ucsf), Tony F (@urooncmd) , Mike L (@_TheUrologist_), and Henry Woo ( @DrHWoo). And I am proud of them.

Many of my most compelling tweets have been published in real news outlets (like on NPR and the Washington Post blog) and even a real article grew from it in Nature Urology. The biotech twitterverse (see Adam Feuerstein) has there hooks in me as well and I have had several consulting jobs as a result.

Like any father I have problems with my kids. They dont listen to my sage advice and they should. To tweet is not to be boring. It is not to be glib and tidy (Hi mom!). That is why we have Facebook. You have several style options for your tweets in the twitterverse and here are a few:

Academic tweets: Boring. These people add pithy tag lines to an interesting article (good example is @drMEisenberg). I have no problem with this approach. It makes for a safe environment and there is no question you have to be safe with your remarks (which I occasionally am not). It is a purely an informational tweet.

Snarky and academic: This is the province of Matt Cooperberg and I. I am vastly more funny. He is what I would describe as almost funny. The strategy is simple – find an article in urology or medicine in general and add a funny comment.  They become strangely profound if done right. Good examples are here ….. or here

Mash-up Tweets: This is hard and rare. It is basically the ability to makes a tweet about a timely topic (could be breaking news) and tie it to something else that is urologic or some other breaking news. Sounds hard? It is. This is an advanced twitter move. My best tweets (judged by RTs) were mashups. Remember my best tweets are actually not available after some time since twitter archives your tweets for a limited time. Here is one ok example

Academic Modified Tweets and/or Snarky Academic Modified tweets:  Modified tweets are taking a tweet and changing it to either to it make shorter or to completely change it to make a funny and/or compelling point. I’m better at funny. This is hard. These are by far my favorite form of tweets. Good one here

Odd ball tweet: I also love just saying something funny totally out of context. Remember do not be boring. This has been championed by @robdelany who is champion tweeter and raunchy comedian. Not everyone likes him but his a great odd ball tweeter. Here is my attempt. It is ok.
There is a lot to teach my people.  Follow good tweeters. Do not tell us about your heartburn, gas, or inlaws (unless its a mashup!). Do not talk to your friends about something silly. Do not add silly hashtags to seem funny. They are never funny. Never. Repeat that over and over until you stop doing it. I will blog frequently about urologic twitter topics now that I am the Senior Consultant and Highly Paid Advisor for Social Media for BJUI. This of course is false but if you keep repeating it…

 

Benjamin Davies is Assistant Professor of Urology at the University of Pittsburgh; Program Director, Urologic Oncology Fellowship and Chief, Division of Urology Shadyside Hospital. His views are his own. @daviesbj

 

Comments on this blog are now closed.

Editorial: Is botulinum toxin not the solution to OAB after all?

Dirk De Ridder
Department of Urology, University Hospital Leuven, Belgium

The article by Mohee et al. highlights a problem that is often neglected: the outomes we see in clinical trials do not predict the success of the therapy in real life. We know this from anticholinergics: the study results are good, but the performance in real life is much poorer. Only 20-40% will continue to take the medication.

For botulinum toxin in OAB it is surprising to see that even in experienced hands only 38.7% of patients continued with the treatment at 36 months. The reasons to abandon the treatment were retention, the need for CISC and urinary tract infections. Moreover, 8.6% of the patients had no response at all after the initial injection.

Of course infections could have been avoided by using prophylactic antibiotics, but the other issues remain. How to explain the primary failures? How to manage the risk of CISC?

Given the fact that most patients abandoned the treatment within the first 3 years, more research would be needed on how to increase the treatment adherence of the patients after the initial injection.

This challenging article also stresses the fact that in a time where only RCTs stand a good chance of being published in journals, good retrospective cohort studies can be extremely important too.

Read the full article

Ten stories of 2012, part II

Thanks for all the helpful input regarding my first blog post. Constructive criticism is always helpful, especially if I am to get better at this.

If you haven’t read it, part 1 is here.

So, in no particular order, part 2 of 2:

+ Metastatic prostate cancer – it’s getting complicated…

2012 was a year of hope for metastatic prostate cancer patients.  First, Enzalutamide (also known as MDV3100), in the context of a phase III RCT, was shown to prolong the survival of men with metastatic prostate cancer after chemo. And just when we thought the year was over, Abiraterone, which was previously shown to improve survival in patients with metastatic prostate cancer after chemotherapy, was found to be beneficial even in chemo-naive patients. All this translates into more complicated algorithms for castrate-resistant prostate cancer.  That said, my question is the following: what happens if these drugs are effective at treating localized prostate cancer? It seems that some medical oncologists are trying to figure that out. Prostatectomists, murky waters lie ahead! Oh wait, I’m part of that group.

+ The changing landscape of surgical education

Times They Are a-Changin’. Residents are working less but don’t sleep more. 16-hour work day restrictions. More women are admitted into surgical fields. Protected nap (sleep) time during calls. Residents not covering floor consults during the day (those are actually the rules where I work). Most trainees now value quality of life above anything else, possibly even the quality of their training (do read this beautiful piece by a Urologist in JAMA: Considering Life Before Lifestyle. Yet, the amount of knowledge a resident needs to consolidate during residency is at least 10-fold greater than what the old geezers had to learn back in the days (the current Campbell-Walsh is 134 chapters, 4320 pages). Whether or not you agree with any of the above (which is irrelevant anyways, because it’s happening whether you like it or not), attending surgeons and urologists are finding it hard to adapt or understand. “Honey, things were much harder back when I was a resident…” How do we evolve as a sub-specialty without compromising surgical education (or lengthening residency)? Status quo is not an option.

+ Radiotherapy for prostate cancer – what’s up with that?

A nice observational study from Sheets et al in the JAMA thematic issue on Comparative Effectiveness Research showed that “use of IMRT compared with conformal radiation therapy was associated with less gastrointestinal morbidity and fewer hip fractures but more erectile dysfunction“. Yet, Jacobs et al, using the same dataset and almost the same study years, showed that the risks of salvage therapy and complications are comparable between the two modalities, for most patients. And let’s not get started about proton-beam therapy. Whilst this costly approach is gaining precedence in the treatment of localized prostate cancer, severe doubts exist regarding its efficacy. The bombshell: another observational study from Yale, based on Medicare data: “Although proton radiotherapy is substantially more costly than IMRT, there was no difference in toxicity in a comprehensive cohort of Medicare beneficiaries with prostate cancer at 12 months post-treatment“. Ouch.  To be perfectly honest (sometimes I’m told I should shut up), it would be hypocrisy for robotic surgery fanboys to condemn proton beam therapy right now. As we all know, it took years before convincing observational data showed that robotic radical prostatectomy is better than open, at some levels. Maybe someone responsible will actually perform a prospective comparative effectiveness assessment between these modalities. As an avid blogger suggests, maybe the proton beams and the robots should fight for world domination.

+ Urology at the forefront of the social media revolution

As a group, we should be proud of how we embraced social media in 2012. In the field of medicine, where anything novel is usually met with smirk and mockery (see: surgery, robot-assisted), social media has been surprisingly well received, thanks to a tight-knit community of twitter champions (if you’re new to twitter, you should definitely follow urologymatch.com’s list of key opinion leaders (KOLs) in Urology. Moreover, the first International Urology Journal Club was held in November 2012 and has been a global success ever since. I’m sure that 2012 was only the start. It will be exciting to see the role of social media in upcoming international meetings such as the EAU, AUA and BAUS. Virtual high-five everyone!

+ Be inspired.

OK, so this one has nothing to do with Urology, or Medicine for that matter. Here’s a toast to the events that shook 2012, and let’s hope that 2013 will be a great year!

 

 

Quoc-Dien Trinh
@qdtrinh

 

Quoc-Dien Trinh is a minimally-invasive urologist and co-director of the Cancer Prognostics and Health Outcomes Unit. His research focuses on patterns of care, costs and outcomes in prostate cancer treatment.

 

Comments on this blog are now closed.

 

International Urology Journal Club on Twitter

International Urology Journal Club on Twitter: The Beginnings of a New Application of Social Media in Urology CME

The International Urology Journal Club on Twitter almost came about by accident, although the formation of such was an inevitability. Over the course of 2012, a number of research papers have been the subjects of discussion amongst urologists on Twitter.

The standout paper as example for discussion in 2012 was the PIVOT study. This generated comments that were difficult to follow unless you were following all of the many participants. Although one could find the majority of the tweets in chronological order by doing a search under the tab “Discover”, it was still dependent upon whether the term PIVOT was used in the tweet or not – it was quite often the case that a comment was made without the term PIVOT being used and these would be missed by a search for PIVOT. In essence, a form of journal club was already happening although there was no organized manner by which all comments could be filed or arranged to provide context. When limited to 140 characters, a tweet can easily lose context if it cannot be connected to other tweets it may refer to or be in reply to. The use of a hashtag provides a filing system for related tweets and had all participants in the PIVOT study discussion used the hashtag #PIVOT, a search under that term would have enabled easy following and review of the discussion pertaining to that topic. The use of a hashtag does require general agreement by contributors that this will be the agreed filing (this is what I call it even though it is not a universal way of describing it) system for the tweets. It also meant that inclusion of long twitter handle names such as @cooperberg_ucsf would not eat into the precious 140 character limit to which we wish to make comment – as we are a tolerant, respectful and good humoured community, we of course continue to tolerate this blight on our character count. (I have incidentally shortened my Twitter name from @DrHenryWoo to @DrHWoo as a donation of 4 precious characters to those who wish to engage me on Twitter).

So how did the International Urology Journal Club on Twitter come about? It all started with Canadian urologist Michael Leveridge sending a few live tweets from his local journal club and nominally used the hastag #quroljc, which stood for Queens Urology Journal Club. A number of urology colleagues around the world, including myself, were intrigued by this.

Following an exchange of tweets, we came to realization that we were effectively engaging in a Twitter urology journal club. We soon realized that in order to do this effectively, we needed a hashtag to which we could all tweet our journal club responses and the hastag #urojc was born.

According to the exchange of tweets above, we can credit Michael Leveridge for coining the hashtag #urojc. On Twitter, it does not take long for the message to spread.

To administer Journal Club, an administrative account @iurojc and specific blog account was established. You will note that the administrative account is @iurojc and not @urojc since the latter had already been taken by another urologist. The #urojc blog carries information about the journal club as well as the tweet logs from the discussions.

In short, a recently published manuscript is selected for each month’s discussion. Such manuscripts are usually those that have been published online ahead of print in order to offer the most cutting edge research discussion. Discussions occur on the first Sunday or Monday of each month depending on which time zone you are in. Tweet discussion is carried out in an asynchronous manner over the course of 48 hours. Since commencing in November 2012, there has been a truly global engagement and with the amplification effect of Social Media, we have seen in excess of 50,000 impressions (a Twitter metric of reach). A novel approach to this format of journal club is the invitation and participation of the lead author and/or corresponding author associated with the paper for discussion – there is no question that this significantly enhances the value of the discussion.

Prior to the commencement of the first #urojc discussion, it was suggested that there should be a prize for the best tweet. This has now been instituted and a #urojc Hall of Fame is now in the making. With the Best Tweet prize for November 2012 being awarded to Ben Davies, it has only fueled his belief that he is indeed the urological King of Twitter. He is, however, the inaugural prize winner and at the top of the list of the #urojc Twitter Hall of Fame. The winner of the December Best Tweet Prize was another Ben, namely Ben Jackson. We thank Urology Match and Nature Reviews in Urology for donating the prizes for November and December respectively. Whilst there were suggestions of a Ben conspiracy, we cannot promise that the January Best Tweet Prize, which has been donated by the Urological Society of Australia and New Zealand (USANZ) will be awarded to a non-Ben participant.

It is our belief that the #urojc is the first truly international clinical journal club discussion taking place on Twitter in an organized manner. Whilst there are local real time Twitter journal club chats and similar discussions in non-clinical areas of health care, this is again a demonstration of how urologists lead the way with the embracement of technology to advance health care. For now, the discussions are on a monthly basis with a focus on uro-oncology. As interest grows, the plan is to expand to twice monthly with the mid-month discussion being on topics such as endourology or voiding dysfunction or female urology or any other area of interest. Do follow @iurojc and put forward your suggestions for papers to discuss. Again remember that the Twitter user name is slightly different to the hashtag, which is #urojc.

We look forward to having you join us for the next #urojc. 

 

Henry Woo is an Associate Professor of Surgery at the Sydney Adventist Hospital Clinical School of the University of Sydney in Australia. He has been appointed as the inaugural BJUI CME Editor. He is currently the coordinator of the International Urology Journal Club on Twitter. Follow him on Twitter @DrHWoo

 

January #urojc paper will be on PHI by @LoebStacy jurology.com/article/S0022-… ncbi.nlm.nih.gov/pubmed/23206426

 

Comments on this blog are now closed.

 

 

What’s the diagnosis?

This young man presented with left loin pain. A non-contrast CT was performed to exclude ureteric stone.

You can type your answers here if you want to compare with our answers, or just click the ‘submit’ button below

[wpsqt name=”Picture of the week – 04/12/2012″ type=”quiz’ label=’

Click here for more Picture Quizzes

“The most read surgical journal on the web”

It is an enormous privilege becoming the new Editor-in-Chief of the BJUI. As an academic it has been my ultimate dream. Thank you for this exciting opportunity to serve our readers and authors. I also wanted to express my gratitude to our editorial board and reviewers without whom this journal would not exist.

Early one morning during the BAUS annual meeting 2012, I had the great pleasure of having breakfast with John Fitzpatrick. He has done wonders with the BJUI and I wish to thank and congratulate him for his excellent leadership, international collaboration and innovative approach, which has established the journal as a global landmark in urology. I asked him to describe his most important contribution to the BJUI in one word. The answer without hesitation was ‘colour’.

John immediately asked me the same question. With equal conviction I uttered the words that would describe the BJUI in the next 5 years –’the web’.

The other day I made my usual trip to the Guy’s Hospital, King’s College London, library. I love reading the new journals as well as archived copies that are stored on the first floor. I have done so regularly for the last 10 years. On this occasion I requested our friendly librarian to guide me towards the new editions of Science and the N Engl J Med. Rather to my astonishment, she said that the first floor had been shut and there were no paper journals there anymore! Instead she directed me to a computer terminal where I could browse every scientific journal with my college user name and password. It was then that I realised that my own library had stopped subscribing to paper journals. I have since learned that many other libraries have done the same. Libraries and not urologists are the largest subscribers of the BJUI. If they do not want paper journals they are just not going to buy them.

Welcome to the green revolution.

Over the next few years it will be my mission to make the BJUI the most read surgical journal on the web. We have not made the mistake of assuming that this is what all our readers want. Therefore, while we make the transition to the web, the paper version continues, but with a few differences. We will be reducing the number of paper issues to once a month. Our readers have told us that as soon as the first edition comes out of its plastic cover, the next one arrives. This is often rather overwhelming for a busy urologist who may find it challenging to find the important messages. A direct result of reducing the number of volumes is that fewer papers will ultimately be published and the acceptance rate will fall to ~15%. A triage system has been introduced whereby papers that are not felt to be suitable for the new journal are returned immediately to the authors. This is not a reflection of the quality of the papers but reduces wastage of valuable time and allows the articles to be submitted elsewhere without delay.

The BJUI website www.bjui.org has been entirely redesigned and, in keeping with our main mission statement, I have gathered a dedicated new team of enthusiastic innovators. You will notice that unlike other journals we have Associate Editors for innovation, impact, web, social media and design. These are young urologists with unique skills allowing us to deliver the BJUI on an exciting web-based platform that will evolve continuously. I hope you can join us on this journey.

The busy modern surgeon has a short attention span. If we cannot attract them to our key messages within 30 seconds of reaching our landing page, it is unlikely that they will stay there for 3 minutes rather than go elsewhere. Extensive studies and searches on web-based metrics have made these facts obvious to me. These are the realities of modern academic publishing. The web-based journal will have a much wider readership, not just amongst urologists but also other doctors, nurses, students and most importantly patients and their families.

With this in mind we have introduced the ‘article of the week’, almost like the headline news of The Times. If most urologists read just this on their iPads or smart phones, rather than ever even look at the paper version, we have successfully made our point. This month one such article is the updated Partin tables. As a predictive tool, they are important to urologists and patients alike and will allow our readers to counsel patients about the potential outcomes after treatment of their prostate cancer.

Another new feature is the BJUI blog for immediacy, HuffPost style; the days of writing a letter to the editor that gets published a year later are no more. Instead, your opinions will be moderated and appear real time on the website. The debate will be timely, educational and enjoyable.

Social media, especially Twitter, will play an important role in highlighting the most important content and allowing rapid interaction during international meetings. We have engaged the services of a group specialising in social media and I urge you to follow the BJUI on Facebook and Twitter. Who knows ‘tweetations’ might become as important as the impact factor, one day soon.

Finally, I wanted to especially thank Francesco Montorsi for inspiring me during dinner one autumn evening in Milan, where I had been invited to review a European Union grant application. The lesson I learnt from him was humility. As the Editor-in-Chief I always remember an important tale published by Hans Christian Andersen in 1837. ‘The Emperor’s New Clothes’ describes what happens when a vain king is paraded by two rogue weavers in his invisible new clothes through the streets of his own capital. I hope I will always manage to avoid the ‘emperor syndrome’. My job is to serve our readers and focus above all on the one thing that is of utmost importance to the BJUI – quality.

Prokar Dasgupta

Twitter: my #eurekamoment #pennydrops #babyvomit

I remember distinctly when the penny dropped for me. It was about 2am on a warm summer’s night in early January 2012 (apologies to those of you shivering in the Northern Hemisphere). I had my one-week old son in one arm, swinging between sleeping and spewing, and an iPad in my other hand, providing distraction between nappy changes and feeds. The sleep-deprivation had dulled my senses considerably and my brain was capable of no more than light reading.

It was then I read a piece in the New York Times online about the power of Twitter in medical communication. Previously, I thought Twitter was the domain of Lady Gaga, Justin Bieber, Kim Kardashian (Kim who?) and various narcissistic cricket and football players. It seemed like puerile nonsense for a generation that I no longer belonged to. However, reading this opinion piece made me think again. It was clear that there is a whole generation of significant academic clinicians, researchers and publishers who have embraced social media and who use Twitter, in particular, to disseminate their work with a speed and reach that is simply unachievable through any other medium. I was struck by various examples of how key scientific publications are first flagged on Twitter and how within hours, responses are made by key opinion leaders and these responses are again disseminated rapidly around the Twittersphere. And although none of the examples were based around urology, it was clear to me that oncologists and surgeons were getting on board the social media rollercoaster.

So between nappy changes and having wiped some baby vomit off my iPad, I logged onto Twitter and created a username. I searched for prostate cancer and urology and quickly found my way to a few key resources and super-users who seemed to have a very active Twitter presence and who were tweeting content that immediately appeared of interest to me. Within a few minutes I had identified a few highly valuable Twitter users to follow and within their lists of followers and those who they were following, I quickly built up a useful stream of tweets dropping into my timeline. And then of course, a few of these Twitterers started following me back, which was mildly exciting. Within a few days and having posted a few tweaks, I began to feel part of the Twittersphere.

As the weeks went by, I continued to be astounded by just how fast information travels on Twitter. While I get emails with the table of contents for the various journals that I subscribe to, these only drop in my inbox every few weeks. Also, because there are a number of significant journals that I do not subscribe to (non-urological mostly), there are many papers published out there that do not come immediately to my attention. Depending on which Twitter sites you follow, all key papers related to your area of interest find their way into your timeline instantaneously as soon as they are published. Not just that, very interesting comment from others also gets to you very quickly. For example, key findings in prostate cancer tend to be picked up by the major US news sites who then invite comment from key leaders in major cancer centres. A typical example is that of the PSA screening recommendations made by the United States Preventive Services Taskforce in June 2012, which provoked huge controversy. Twitter came to life and key opinion leaders such as Matt Cooperberg (@cooperberg_ucsf) helped drive the conversation through Twitter and blogs (e.g.The Huffington Post blog) at lightning speed. These comments get tweeted out and responses to these comments also get blogged and within hours of a paper being published you have news of the paper, expert comment and wider reaction…… all in 140 characters or less!

And while none of us have much time in the day to add an extra task, I find that waiting for my coffee in the morning or while the resident puts an arterial line in my next patient, there are a few spare moments in the day where the Twitter app on my iPhone comes to life. Twitter is perfectly suited to the smart phone user and that is where the majority of tweets around the world are generated from. It is also perfectly suited for one of the other very exciting areas in which I have seen Twitter play a very useful role – that of conferencing. At the EAU in Paris, a small but energetic group of Twitter users started tweeting content from various sessions at this large meeting and started engaging with other Twitter users around the world. For me, I believe conferencing is about to be transformed by the power of social media but more about that soon.

For now, at the new BJUI, we want to grow the audience and get you all to join the conversation. Through Twitter, blogging, Facebook, YouTube and other social media platforms, we are building for the future of communication in urology. The next generation of trainees will be deeply embedded in all of these platforms and will expect to be engaged through them. We are entering a new generation of medical communication – come join the conversation.

Declan Murphy
@declangmurphy

 

Declan Murphy is Honorary Clinical Associate Professor at the Department of Surgery, University of Melbourne, St Vincent’s Hospital and Director of Robotic Surgery at the Peter MacCallum Cancer Centre. He had previously been consultant urological surgeon at Guys & St Thomas’ NHS Foundation Trust in London.

 

Comments on this blog are now closed.

© 2024 BJU International. All Rights Reserved.